For individuals who do not regularly use substances such as Ritalin or alcohol, the response to NMN IV therapy could be different, as they are likely starting from a healthier baseline. Here’s a breakdown of the potential percentage changes in key health markers after the first NMN IV (300mg) versus after two weeks of twice-weekly NMN IV treatments:
After the First IV (300mg):
Heart Rate Variability (HRV):
Expected Change: 5-10% improvement
As NMN supports mitochondrial function and energy production, there may be an initial boost in HRV, reflecting improved autonomic balance and stress resilience.
Resting Heart Rate (RHR):
Expected Change: 3-5% reduction
A slight decrease in resting heart rate may be observed as energy metabolism and cellular repair processes begin to improve.
Sleep Quality (REM and Deep Sleep):
Expected Change: 5-8% improvement
Some individuals may experience better sleep quality due to NMN’s potential to enhance recovery, though more substantial changes often require multiple treatments.
Body Temperature Regulation:
Expected Change: Minimal to 2% improvement
Changes in body temperature regulation may be less noticeable after a single dose, but small improvements in stability could occur as inflammation is slightly reduced.
Sleep Latency (Time to Fall Asleep):
Expected Change: 5-10% reduction
NMN may help improve circadian rhythm regulation, allowing individuals to fall asleep faster after the first IV.
After 2 Weeks of Twice-Weekly IVs (300mg each):
Heart Rate Variability (HRV):
Expected Change: 15-25% improvement
Consistent NMN treatments may result in significantly higher HRV, reflecting enhanced autonomic balance, better stress recovery, and improved overall cardiovascular health.
Resting Heart Rate (RHR):
Expected Change: 5-8% reduction
More noticeable reductions in resting heart rate may occur with cumulative mitochondrial improvements and better energy efficiency.
Sleep Quality (REM and Deep Sleep):
Expected Change: 10-15% improvement
Sleep patterns, especially deep and REM sleep phases, may show marked improvements after regular NMN IV therapy, as the body’s repair processes are enhanced.
Body Temperature Regulation:
Expected Change: 3-5% improvement
More stable and consistent body temperature during sleep could reflect better metabolic and inflammatory control after multiple sessions.
Sleep Latency (Time to Fall Asleep):
Expected Change: 10-15% reduction
After two weeks, NMN may further improve sleep latency, as the individual’s circadian rhythm and recovery processes become more regulated.
Summary:
After the First IV: Moderate changes (3-10%) in most health metrics are expected, primarily related to mitochondrial function and recovery.
After 2 Weeks of Twice-Weekly IVs: More substantial improvements (10-25%) in HRV, sleep quality, and resting heart rate, with enhanced benefits from cumulative effects.
These figures are based on general observations from NMN IV therapy research and clinical outcomes. Individual responses will vary based on personal health status, lifestyle, and other factors.
While NAD+ was a novel approach - the issues surrounding it are less than exciting. One NMN IV is equivalent to 2 days of 500-1000mg NAD+, takes 30 minutes (not 2 hours or more) and has no discomfort. In addition to cycling over 20 days vs 14 inside the body.